[HTML][HTML] Breast cancer metastasis: mechanisms and therapeutic implications

M Park, D Kim, S Ko, A Kim, K Mo, H Yoon - International journal of …, 2022‏ - mdpi.com
Breast cancer is the most common malignancy in women worldwide. Metastasis is the
leading cause of high mortality in most cancers. Although predicting the early stage of breast …

[HTML][HTML] The role of tumor-associated macrophages in the progression and chemoresistance of ovarian cancer

M Nowak, M Klink - Cells, 2020‏ - mdpi.com
Tumor-associated macrophages (TAMs) constitute the main population of immune cells
present in the ovarian tumor microenvironment. These cells are characterized by high …

Spatial transcriptomics depict ligand–receptor cross-talk heterogeneity at the tumor-stroma interface in long-term ovarian cancer survivors

S Ferri-Borgogno, Y Zhu, J Sheng, JK Burks… - Cancer …, 2023‏ - aacrjournals.org
Advanced high-grade serous ovarian cancer (HGSC) is an aggressive disease that
accounts for 70% of all ovarian cancer deaths. Nevertheless, 15% of patients diagnosed …

Interferon-ε is a tumour suppressor and restricts ovarian cancer

ZRC Marks, NK Campbell, NE Mangan… - Nature, 2023‏ - nature.com
High-grade serous ovarian cancers have low survival rates because of their late
presentation with extensive peritoneal metastases and frequent chemoresistance, and …

An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment

T Motohara, K Masuda, M Morotti, Y Zheng… - Oncogene, 2019‏ - nature.com
Metastasis is a complex multistep process that involves critical interactions between cancer
cells and a variety of stromal components in the tumor microenvironment, which profoundly …

Current insights into the metastasis of epithelial ovarian cancer-hopes and hurdles

M Yousefi, S Dehghani, R Nosrati, M Ghanei… - Cellular Oncology, 2020‏ - Springer
Background Ovarian cancer is the most lethal gynecologic cancer and the fifth leading
cause of cancer-related mortality in women worldwide. Despite various attempts to improve …

Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1

V Krishnan, S Tallapragada, B Schaar, K Kamat… - Communications …, 2020‏ - nature.com
The omentum is the most common site of ovarian cancer metastasis. Immune cell clusters
called milky spots are found throughout the omentum. It is however unknown if these …

Hormonal therapy for gynecological cancers: how far has science progressed toward clinical applications?

S Mitra, MS Lami, A Ghosh, R Das, TE Tallei… - Cancers, 2022‏ - mdpi.com
Simple Summary The most common therapies for severe and recurrent gynecological
cancers are hormone therapy and chemotherapy, and responsiveness to therapy is a key …

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations

J Jabs, FM Zickgraf, J Park, S Wagner… - Molecular systems …, 2017‏ - embopress.org
Cancer drug screening in patient‐derived cells holds great promise for personalized
oncology and drug discovery but lacks standardization. Whether cells are cultured as …

Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes

L Giannopoulou, M Zavridou, S Kasimir-Bauer… - Translational …, 2019‏ - Elsevier
Ovarian cancer still remains the most lethal female cancer, since in most cases it is
diagnosed at an advanced stage. Usually after completion of primary treatment …